Sampre Nutritions Clarifies Social Media Rumours About Combined Deals Worth INR 100 Crores
Sampre Nutritions Limited issued a clarification to BSE addressing social media rumours about alleged combined deals worth INR 100 crores with Reliance, Tolaram and Rama Exports. The company clarified it has separate independent agreements with these entities, properly disclosed to exchanges on different dates in 2025, but no combined deal as alleged on Telegram channels. The company is not associated with these social media platforms and advised investors to rely only on official exchange filings.

*this image is generated using AI for illustrative purposes only.
Sampre nutritions Limited has issued a formal clarification to BSE Limited addressing rumours circulating on social media platforms about alleged business deals. The clarification, dated 18 February 2026, responds to BSE's inquiry regarding information spreading on Telegram channels that claimed the company had entered into significant combined agreements.
Social Media Allegations Addressed
The rumours originated from Telegram channels named "NSE BSE STOCKS" and "Trading Chart," which alleged that Sampre Nutritions had entered into a combined deal with three major companies. The social media posts claimed this arrangement would generate business of approximately INR 100 crores over a period of three years.
| Allegation Details: | Information |
|---|---|
| Alleged Partners: | Reliance, Tolaram and Rama Exports |
| Claimed Business Value: | INR 100 crores |
| Alleged Timeline: | Three years |
| Source Platforms: | Telegram channels |
Company's Official Position
Sampre Nutritions clarified that while it has business relationships with the mentioned entities, there is no combined or joint agreement as alleged. The company emphasized that it has executed separate independent agreements with each entity in the ordinary course of business.
Actual Agreements Disclosed
The company provided details of the actual agreements that were properly disclosed to the exchange:
| Agreement Type: | Partner Company | Disclosure Date |
|---|---|---|
| Manufacturing Agreement: | Tolaram Wellness Ltd. | 28 August 2025 |
| Manufacturing Agreement: | Rama Exports | 22 August 2025 |
| Manufacturing/Supply Agreement: | Reliance Consumer Products Limited | 17 October 2025 |
Regulatory Compliance and Market Impact
The company stated it is not associated with the mentioned Telegram channels and has not authorized dissemination of such information. Management became aware of the circulation only after BSE's communication and is examining appropriate steps regarding the matter.
Regarding market impact, Sampre Nutritions noted that while certain fluctuations in price and trading volumes have been observed, such movements are not uncommon in normal market activity. The company confirmed that based on currently available information, there is no material information beyond what has already been disclosed that warrants further disclosure under Regulation 30.
Investor Advisory
The company advised investors and shareholders to rely only on information officially filed with the Stock Exchanges. The clarification was signed by Managing Director Brahma Gurbani and submitted under Regulation 30(11) of SEBI (LODR) Regulations, 2015, which governs rumour verification requirements.
Historical Stock Returns for Sampre Nutritions
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +4.95% | -22.59% | -20.20% | +14.84% | +133.37% | +340.09% |



























